Literature DB >> 6195047

A prospective follow-up study of panretinal photocoagulation in preventing neovascular glaucoma following ischaemic central retinal vein occlusion.

L Laatikainen.   

Abstract

Fifteen consecutive eyes with central retinal vein occlusion (CRVO) and extensive capillary non-perfusion were treated by panretinal photocoagulation using argon laser. Of these eyes six had chronic glaucoma and one had acute angle-closure glaucoma when first seen. One developed neovascular glaucoma before treatment. After photocoagulation iris new vessels appeared in two eyes with pre-existing glaucoma. In one case the new vessels later regressed without further treatment. The prevalence of neovascular glaucoma was considerably less than has been reported in untreated eyes with ischaemic-type CRVO. Poor dilatation of the pupil due to pre-existing glaucoma, cataract and/or massive retinal oedema put a limit on the extent of treatment.

Entities:  

Mesh:

Year:  1983        PMID: 6195047     DOI: 10.1007/bf02308081

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  17 in total

1.  Preliminary report on effect of retinal panphotocoagulation on rubeosis iridis and neovascular glaucoma.

Authors:  L Laatikainen
Journal:  Br J Ophthalmol       Date:  1977-04       Impact factor: 4.638

2.  Fluorescein angiography of the vessels of the iris in pseudoexfoliation of the lens capsule, capsular glaucoma and some other forms of glaucoma.

Authors:  A Vannas
Journal:  Acta Ophthalmol Suppl       Date:  1969

3.  [Therapeutic results of photo-coagulation in branch and total retinal vein occlusion (author's transl)].

Authors:  G Theodossiadis; J Charamis; P Velissaropoulos
Journal:  Klin Monbl Augenheilkd       Date:  1974-06       Impact factor: 0.700

4.  Transient angle-closure glaucoma after retinal vein occlusion. Report of two cases.

Authors:  S W Hyams; E Neumann
Journal:  Br J Ophthalmol       Date:  1972-04       Impact factor: 4.638

Review 5.  Photocoagulation in retinal vein occlusion.

Authors:  S C Sedney
Journal:  Doc Ophthalmol       Date:  1976-01-28       Impact factor: 2.379

6.  Fluorescein angiography and its prognostic significance in central retinal vein occlusion.

Authors:  L Laatikainen; E M Kohner
Journal:  Br J Ophthalmol       Date:  1976-06       Impact factor: 4.638

7.  Viscosity and retinal vein thrombosis.

Authors:  C P Ring; T C Pearson; M D Sanders; G Wetherley-Mein
Journal:  Br J Ophthalmol       Date:  1976-06       Impact factor: 4.638

8.  Panretinal photocoagulation in central retinal vein occlusion: A randomised controlled clinical study.

Authors:  L Laatikainen; E M Kohner; D Khoury; R K Blach
Journal:  Br J Ophthalmol       Date:  1977-12       Impact factor: 4.638

9.  Transient angle-closure glaucoma in central retinal vein occlusion.

Authors:  M A Bloome
Journal:  Ann Ophthalmol       Date:  1977-01

10.  Efficacy of panretinal photocoagulation in preventing neovascular glaucoma following ischemic central retinal vein obstruction.

Authors:  L E Magargal; G C Brown; J J Augsburger; L A Donoso
Journal:  Ophthalmology       Date:  1982-07       Impact factor: 12.079

View more
  8 in total

1.  Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study.

Authors:  S S Hayreh; M R Klugman; P Podhajsky; G E Servais; E S Perkins
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

2.  Clinical and infrared pupillometry in central retinal vein occlusion.

Authors:  P A Bloom; D Papakostopoulos; Y Gogolitsyn; J A Leenderz; S Papakostopoulos; R H Grey
Journal:  Br J Ophthalmol       Date:  1993-02       Impact factor: 4.638

3.  Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase.

Authors:  S S Hayreh; M R Klugman; M Beri; A E Kimura; P Podhajsky
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

4.  The electro-oculogram in central retinal vein occlusion.

Authors:  D Papakostopoulos; P A Bloom; R H Grey; J C Dean Hart
Journal:  Br J Ophthalmol       Date:  1992-09       Impact factor: 4.638

5.  Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma: a survey on 23 cases throughout 12-month follow-up.

Authors:  Ciro Costagliola; Ugo Cipollone; Michele Rinaldi; Michele della Corte; Francesco Semeraro; Mario R Romano
Journal:  Br J Clin Pharmacol       Date:  2008-11       Impact factor: 4.335

6.  [Prophylactic pan-coagulation from ischemic central vein occlusions? Practicability of the results from the Central Vein Occlusion Study Group].

Authors:  I Schmack; S Dithmar
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

7.  Intravitreal bevacizumab for the treatment of neovascular glaucoma associated with central retinal artery occlusion.

Authors:  Min Sagong; Jinseon Kim; Woohyok Chang
Journal:  Korean J Ophthalmol       Date:  2009-09-08

8.  Management of intraocular pressure elevation during hemodialysis of neovascular glaucoma: a case report.

Authors:  P Frezzotti; C Menicacci; S A Bagaglia; P Mittica; F Toto; I Motolese
Journal:  BMC Ophthalmol       Date:  2016-03-05       Impact factor: 2.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.